Edition:
United States

Teleflex Inc (TFX.N)

TFX.N on New York Stock Exchange

212.72USD
1:23pm EDT
Change (% chg)

$-2.87 (-1.33%)
Prev Close
$215.59
Open
$215.69
Day's High
$215.69
Day's Low
$212.62
Volume
11,947
Avg. Vol
76,826
52-wk High
$216.09
52-wk Low
$136.64

TFX.N

Chart for TFX.N

About

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments:... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $9,697.51
Shares Outstanding(Mil.): 44.98
Dividend: 0.34
Yield (%): 0.63

Financials

  TFX.N Industry Sector
P/E (TTM): 44.88 32.05 15.59
EPS (TTM): 4.80 -- --
ROI: 5.60 13.42 -8.43
ROE: 10.56 15.86 -8.00

BRIEF-Arrow Seldinger Arterial Catheterization Device receives FDA market clearance - Teleflex Inc

* Teleflex Inc says that its Arrow Seldinger Arterial Catheterization Device received market clearance from U.S. Food And Drug Administration

Jul 24 2017

BRIEF-Teleflex commences phase I clinical study of RePlas freeze-dried plasma

* Teleflex (TFX) announces commencement of phase i clinical study (FDP-1) of RePlas™ freeze-dried plasma

May 15 2017

BRIEF-Teleflex receives FDA 510(k) clearance for Arrow AC3 Optimustm Intra-Aortic Balloon Pump

* Teleflex receives fda 510(k) clearance for the arrow® ac3 optimustm intra-aortic balloon pump (iabp)

May 02 2017

BRIEF-Pyng receives securityholder approval for acquisition by Teleflex

* Pyng receives securityholder approval for acquisition by Teleflex Source text for Eikon: Further company coverage:

Mar 27 2017

BRIEF-Teleflex announces U.S. commercial launch of spectre guidewire

* Teleflex Inc says has announced 510(k) clearance by Food and Drug Administration and U.S. commercial launch of spectre guidewire Source text for Eikon: Further company coverage:

Mar 14 2017

BRIEF-Teleflex posts Q4 EPS of $1.29 from continuing operations

* Teleflex reports fourth quarter and full year 2016 results; provides 2017 guidance

Feb 23 2017

BRIEF-Teleflex announces 510(k) clearance and US launch of trapliner catheter

* Teleflex (TFX) announces 510(k) clearance and US launch of trapliner catheter Source text for Eikon: Further company coverage:

Feb 22 2017

BRIEF-Vascular Solutions shareholders approve acquisition by Teleflex

* Vascular Solutions shareholders approve acquisition by Teleflex

Feb 16 2017

Competitors

  Price Chg
C R Bard Inc (BCR.N) $321.01 -1.00
Medtronic PLC (MDT.N) $85.50 -0.43
Becton Dickinson and Co (BDX.N) $202.61 -1.66

Earnings vs. Estimates